Triple
T3767712
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Certificates of Suitability |
E82718
|
entity |
| Predicate | recognizedBy |
P653
|
FINISHED |
| Object |
European medicines regulatory authorities
European medicines regulatory authorities are national and regional agencies in Europe responsible for evaluating, authorizing, and monitoring the safety, quality, and efficacy of medicinal products.
|
E387633
|
NE FINISHED |
How this triple was built (4 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: European medicines regulatory authorities | Statement: [Certificates of Suitability, recognizedBy, European medicines regulatory authorities]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: European medicines regulatory authorities Context triple: [Certificates of Suitability, recognizedBy, European medicines regulatory authorities]
-
A.
European Medicines Agency
The European Medicines Agency is the European Union’s regulatory authority responsible for the scientific evaluation, supervision, and safety monitoring of medicines for human and veterinary use.
-
B.
Committee for Medicinal Products for Human Use
The Committee for Medicinal Products for Human Use is the European Medicines Agency’s expert body responsible for evaluating and providing scientific opinions on the safety, quality, and efficacy of medicines for human use in the European Union.
-
C.
European Directorate for the Quality of Medicines & HealthCare
The European Directorate for the Quality of Medicines & HealthCare is a Council of Europe body responsible for developing quality standards and guidance to ensure the safety and efficacy of medicines and improve healthcare across member states.
-
D.
European Union pharmaceutical legislation
European Union pharmaceutical legislation is the body of EU laws and regulations that governs the authorization, supervision, safety, and quality of medicines for human and veterinary use across member states.
-
E.
Committee for Proprietary Medicinal Products
The Committee for Proprietary Medicinal Products was a former scientific committee of the European Union responsible for evaluating and issuing opinions on the quality, safety, and efficacy of human medicinal products before it was replaced by the European Medicines Agency’s current committee structure.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg
Description generation
gpt-5.1
Instruction
Generate a one-sentence description of the target entity. You are given a context triple in the form (subject, predicate, object), where the object is the target entity. # Instructions Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. Avoid repeating the information from the triple, unless really essential. # Response Format Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: European medicines regulatory authorities Triple: [Certificates of Suitability, recognizedBy, European medicines regulatory authorities]
Generated description
European medicines regulatory authorities are national and regional agencies in Europe responsible for evaluating, authorizing, and monitoring the safety, quality, and efficacy of medicinal products.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: European medicines regulatory authorities Target entity description: European medicines regulatory authorities are national and regional agencies in Europe responsible for evaluating, authorizing, and monitoring the safety, quality, and efficacy of medicinal products.
-
A.
European Medicines Agency
The European Medicines Agency is the European Union’s regulatory authority responsible for the scientific evaluation, supervision, and safety monitoring of medicines for human and veterinary use.
-
B.
Committee for Medicinal Products for Human Use
The Committee for Medicinal Products for Human Use is the European Medicines Agency’s expert body responsible for evaluating and providing scientific opinions on the safety, quality, and efficacy of medicines for human use in the European Union.
-
C.
European Directorate for the Quality of Medicines & HealthCare
The European Directorate for the Quality of Medicines & HealthCare is a Council of Europe body responsible for developing quality standards and guidance to ensure the safety and efficacy of medicines and improve healthcare across member states.
-
D.
European Union pharmaceutical legislation
European Union pharmaceutical legislation is the body of EU laws and regulations that governs the authorization, supervision, safety, and quality of medicines for human and veterinary use across member states.
-
E.
Committee for Proprietary Medicinal Products
The Committee for Proprietary Medicinal Products was a former scientific committee of the European Union responsible for evaluating and issuing opinions on the quality, safety, and efficacy of human medicinal products before it was replaced by the European Medicines Agency’s current committee structure.
- F. None of above. chosen
Provenance (5 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69ad8b207b0081909d2b48843fbd8795 |
completed | March 8, 2026, 2:43 p.m. |
| NER | Named-entity recognition | batch_69adcc2bdf6c819088d3c6ace83ca5ea |
completed | March 8, 2026, 7:21 p.m. |
| NED1 | Entity disambiguation (via context triple) | batch_69b4f0373bd88190aaaf45f253c4ee17 |
completed | March 14, 2026, 5:20 a.m. |
| NEDg | Description generation | batch_69b4f0a3f9b481909d01bd69a0e1a309 |
completed | March 14, 2026, 5:22 a.m. |
| NED2 | Entity disambiguation (via description) | batch_69b4f14246e88190921e35b19f8531e7 |
completed | March 14, 2026, 5:25 a.m. |
Created at: March 8, 2026, 3:35 p.m.